Page last updated: 2024-10-17

n(1)-methylnicotinamide and Myocardial Ischemia

n(1)-methylnicotinamide has been researched along with Myocardial Ischemia in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, SM1
Park, JC1
Shin, MJ1
Lee, H1
Oh, J1
Ryu, DH1
Hwang, GS1
Chung, JH1

Other Studies

1 other study available for n(1)-methylnicotinamide and Myocardial Ischemia

ArticleYear
¹H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure.
    Clinical biochemistry, 2011, Volume: 44, Issue:4

    Topics: Acetic Acid; Acetone; Aged; Case-Control Studies; Cytosine; Energy Metabolism; Female; Glycine; Hear

2011